Table 3.
Group | Target | ||||
---|---|---|---|---|---|
Ca (mmol/L) |
P (mmol/L) |
ALP (U/L) |
E2
(pg/mL) |
Hyp (µg/mL) |
|
Sham | 2.36 ± 0.13** | 1.56 ± 0.12** | 82.43 ± 12.47** | 26.99 ± 6.08*** | 28.86 ± 2.19* |
OVX | 2.54 ± 0.11 | 1.78 ± 0.15 | 108.58 ± 16.96 | 10.27 ± 2.65 | 31.43 ± 1.78 |
OVX + N | 2.43 ± 0.12* | 1.65 ± 0.11* | 93.64 ± 10.38* | 16.43 ± 3.62** | 29.75 ± 1.98 |
OVX + H | 2.43 ± 0.11 | 1.65 ± 0.07* | 94.68 ± 11.35* | 10.06 ± 3.54 | 37.43 ± 2.96*** |
OVX + M | 2.41 ± 0.14 | 1.70 ± 0.09 | 97.33 ± 10.68 | 10.31 ± 4.05 | 36.68 ± 3.29** |
OVX + L | 2.45 ± 0.10 | 1.69 ± 0.15 | 94.22 ± 15.53 | 10.04 ± 4.06 | 34.38 ± 4.14 |
Note: *P < 0.05, **P < 0.01, and ***P < 0.001 compared with OVX group.